Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Chennekatu P. Peter"'
Morphological Changes in the Pituitary Gland of Dogs Chronically Exposed to Exogenous Growth Hormone
Autor:
Lea G. Stabinski, Matthew J. van Zwieten, Sylvain Molon-Noblot, Chennekatu P. Peter, Pierre Duprat, Srinivasa Prahalada, Philippe Laroque, Chao-Min Hoe
Publikováno v:
Toxicologic Pathology. 26:201-206
Growth hormone (GH) synthesis and release from the pituitary is regulated by hypothalamic releasing hormone, insulin-like growth factor-1 (IGF-1). and somatostatin. However, the potential effects of pharmacological doses of exogenous GH on the pituit
Autor:
Lea G. Stabinski, Philippe Laroque, Sylvain Molon-Noblot, Pierre Duprat, Srinivasa Prahalada, Matthew J. van Zwieten, Chennekatu P. Peter, Chao-Min Hoe
Publikováno v:
Toxicologic Pathology. 26:207-212
Administration of growth hormone (GH) results in increased body weight gain in dogs. Increased body weight gain is believed to be a result of the trophic effect of GH on the musculoskeletal system. However, edema is one of the side effects described
Autor:
Howard Y. Chen, Chennekatu P. Peter, Lea G. Stabinski, Dan Holder, Darryl H. Patrick, Srinivasa Prahalada, Richard E. Morrissey, Matthew J. van Zwieten, Georges De Burlet
Publikováno v:
Toxicologic Pathology. 26:185-200
The purpose of this study was to evaluate the pharmacological and toxicological effects of exogenous GH administration in normal adult dogs. Because porcine GH (pGH) is structurally identical to canine GH, pGH was selected for a 14-wk study in dogs.
Publikováno v:
Journal of Toxicology: Cutaneous and Ocular Toxicology. 16:9-17
The results of 11 ocular irritation studies in rabbits, dogs, and monkeys treated with 2,3, or 4% dorzolamide hydrochloride (DZ), a new topical ocular carbonic anhydrase inhibitor, are presented. Additional interaction studies were conducted with oth
Autor:
Chennekatu P. Peter, M.J. van Zwieten, Srinivasa Prahalada, Philippe Laroque, S M Cohen, Pierre Duprat, Keith A. Soper, S Molon-Noblot
Publikováno v:
The Prostate. 27:121-128
The objective of this study was to determine the effects of 2 different 5-alpha reductase inhibitors (finasteride and MK-0434) on the glandular and stromal compartments of hyperplastic canine prostates. In this study, dogs received 1 of the 2 compoun
Autor:
Delwin L. Bokelman, Keith A. Soper, Matthew J. Van Zwieten, Srinivasa Prahalada, Phillip R. Hertzog, Kevin P. Keenan, Lea R. Gordon, Chennekatu P. Peter
Publikováno v:
Urology. 43:680-685
Objective. To determine any potential direct and/or indirect effects of elevated intraprostatic T levels on the prostates of rats chronically (1–2 years) exposed to high doses (160 mg/kg/day) of finasteride, a selective inhibitor of 5-alpha reducta
Autor:
Walter Bagdon, Joe D. Burek, Srinivasa Prahalada, M.J. van Zwieten, T. M. Nett, Keith A. Soper, Chennekatu P. Peter, J. A. Majka, James S. MacDonald
Publikováno v:
Fundamental and Applied Toxicology. 22:211-219
Finasteride is a selective inhibitor of the enzyme 5 alpha-reductase which is responsible for the conversion of testosterone (T) to dihydrotestosterone (DHT). Finasteride is indicated for the treatment of benign prostatic hyperplasia in man (approxim
Autor:
Peter H. Berry, Lea R. Gordon, Chennekatu P. Peter, Christine Boussiquet-Leroux, Nicholas Tonkonoh, G. Durand-Cavagna, Roger A. Owen, Sylvain Molon-Noblot
Publikováno v:
Toxicologic Pathology. 21:449-455
Renal papillary cytoplasmic granularity (RPCG) induced by carbonic anhydrase inhibitors (CAIs) in rats is characterized by the accumulation of dense secondary lysosomes in epithelial, endothelial, and interstitial cells and may be related to drug-ind
Autor:
Mark A. Cukierski, Alice F. Tarantal, R. Tarara, Bill L. Lasley, R. T. Robertson, David L. Hess, Srinivasa Prahalada, Andrew G Hendrickx, Chennekatu P. Peter
Publikováno v:
Teratology. 46:429-438
Norfloxacin, an orally active fluoroquinolone antimicrobial, has been reported to be embryolethal but not teratogenic when administered to pregnant cynomolgus macaques prior to gestational day (GD) 36 at doses ≤200 mg/kg/day. Additional studies hav
Autor:
Christine Boussiquet-Leroux, Chennekatu P. Peter, G. Durand-Cavagna, Roger A. Owen, L. R. Gordon
Publikováno v:
Fundamental and Applied Toxicology. 18:137-143
Investigations of MK-0927 and acetazolamide, both carbonic anhydrase inhibitors (CAIs), showed that urothelial hyperplasia develops in rats and mice, but not in rabbits, dogs, or monkeys. Rats given MK-0927 orally had a rapid onset of the change whic